BioClinica Corporation

Bioclinica is an integrated clinical life science solutions provider, delivering powerful insight into clinical trial development, assuring greater client success in bringing medical therapies to market for people around the world. Through deep medical, scientific, and technology expertise, Bioclinica provides medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments; clinical trial management software; and drug safety solutions. Bioclinica’s global team of life science experts serve more than 500 pharmaceutical, biotechnology, and device organizations – including the top 20 biopharmaceutical companies and leading CROs – through locations in North America, Europe, and Asia.
Technology: CRO
Industry: CRO, Imaging
Headquarters: Princeton, New Jersey
Founded Date: 1990
Employees Number: 1001-5000
Funding Status: Privately Held
Acquisitions Number: 11
Investors Number: 1
Total Funding: $13,714,382.00
Estimated Revenue: $100M to $500M
Last Funding Date: 2013-01-01
Last Funding Type: Venture - Series Unknown

Visit Website
general@bioclininca.com
@bioclinica
Register and Claim Ownership